Correlation Between Novo Nordisk and Angion Biomedica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Angion Biomedica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Angion Biomedica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Angion Biomedica Corp, you can compare the effects of market volatilities on Novo Nordisk and Angion Biomedica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Angion Biomedica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Angion Biomedica.

Diversification Opportunities for Novo Nordisk and Angion Biomedica

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Novo and Angion is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Angion Biomedica Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Angion Biomedica Corp and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Angion Biomedica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Angion Biomedica Corp has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Angion Biomedica go up and down completely randomly.

Pair Corralation between Novo Nordisk and Angion Biomedica

If you would invest  1,000.00  in Angion Biomedica Corp on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Angion Biomedica Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy1.56%
ValuesDaily Returns

Novo Nordisk AS  vs.  Angion Biomedica Corp

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Angion Biomedica Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Angion Biomedica Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Angion Biomedica is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Novo Nordisk and Angion Biomedica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Angion Biomedica

The main advantage of trading using opposite Novo Nordisk and Angion Biomedica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Angion Biomedica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Angion Biomedica will offset losses from the drop in Angion Biomedica's long position.
The idea behind Novo Nordisk AS and Angion Biomedica Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites